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Although factors influencing the persistence  of experimental  pyelonephritis have 
been  extensively  investigated,  the  role  of  immunity  against  the  specific  infecting 
organism has not been  elucidated  (1,  2).  Since these  organisms are usually  Gram- 
negative  bacilli,  it  is  reasonable  to  suppose  that  factors determining  resistance  to 
Gram-negative infection in general might apply to pyelonephritis caused by Gram- 
negative organisms as well. 
Resistance  to infection caused by Gram-negative bacteria is of two general types 
(3). The first form of acquired resistance, which may develop within a few hours after 
injection of endot0xin, is not type-specific and is of rather short duration, persisting for 
a few days to several weeks (4, 5).  Evidence that non-specific resistance modifies the 
clinical course of pyelonephritis has been advanced by several investigators. Braude 
and Siemienski demonstrated resistance of this type in pyelonephritic rats by showing 
an accelerated clearance of endotoxin from the plasma of pyelonephrific as compared 
with normal rats (3). McCabe also demonstrated heterologous tolerance to a pyrogenic 
stimulus both in rabbits and in patients with pyelonephritis as compared with normals 
(6, 7). Thus, non-specific resistance appears to play a role in the course of pyeloneph- 
riffs, although it is not clear that it influences  either the existing infection in the kidney 
or  reinfection. 
The  second  form  of  acquired  resistance  to  Gram-negative  infections  is  that  of 
classical acquired immunity, which is associated with the  appearance  of circulating 
antibodies after the 1st week, is type-specific, and persists for weeks.  Immunization 
with somatic antigens from a variety of Gram-negative bacilli has been clearly demon- 
strated  to produce specific  protection against subsequent  infection.  Freter  reported 
that guinea pigs could be protected against death from enteric cholera infection by 
active  immunization  with  cholera  O  vaccine  (8).  Landy,  Johnson,  Webster,  and 
Sagin observed that administration  of Boivin-type Salmonella typhosa endotoxin  to 
mice afforded  a  high  degree  of protection  against  subsequent  challenge  by  an  O- 
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agglutinable strain of S.  typhasa  (9).  O antibody was quite ineffective in protecting 
mice against challenge with an O-inagglutinable Vi  +  O strain of S. typhosa  (strain 
Ty2). Subsequently, Gaines, Landy, Edsall, Mandel, Trapani, and Benenson reported 
that  whole  bacterial  typhoid  vaccine  afforded  chimpanzees  significant  protection 
against  a  challenge  capable  of  inducing  disease  in  non-immunized  animals  (10). 
Immunization with the purified antigen induced no discernible protection. However, 
the  challenge  strain  of S.  typhosa  employed  in  these  studies  was Ty2, which  was 
described earlier from the  same laboratories as O-inagglutinable  and  against which 
O antibody was ineffective in protecting mice. Ribi, Hoyer, Milner, Perrine, Larson, 
and  Goode found that specific active immunity could be demonstrated in mice im- 
munized with purified endotoxins from Salmonella enteritidis if antibodies to O anti- 
gens were produced  (11).  Abernathy  demonstrated  specific  protection  against sub- 
lethal murine brucellosis by immunizing mice with Brucella melitemis endotoxin (12). 
Weyrauch,  Rosenberg,  Amar,  and  Redor  observed  amelioration  of  obstructive 
Escherichia  coli  pyelonephritis  in  rabbits  immunized  with  an  autogenous  vaccine; 
however, the protection was only "slight" (13).  Braude and Siemienski have recently 
reported experiments demonstrating protection against hematogenous pyelonephritis 
in rats immunized with either Escherichia coli or Proteus mirabilis endotoxin; the only 
evidence advanced to indicate that this protection is a result of specific immunity is a 
reference to a preliminary report of our work concerning both protection by passively 
transferred antibody and the specificity of such protection  (3,  14). 
Conclusions regarding development of circulating antibodies during  the course of 
either experimental or clinical pyelonephritis have been controversial. McCabe and 
Jackson  uniformly  demonstrated  high  titers  of  specific  agglutinating  antibody  5 
weeks after retrograde infection with either a  strain of E. coli or a  strain of entero- 
coccus (15).  However, since agglutinins were present during the phase at which late 
bacterial proliferation ensued,  they concluded  that specific bacterial agglutinins  did 
not eliminate chronic infection.  An  antibody response during  the  course of urinary 
tract infections in patients was observed in 6 of 22 patients studied by Hughes (16). 
From these data he concluded that localized disease failed to evoke immune responses. 
Needell, Neter, Staubitz, and Bingham studied  20 patients with infection of the uri- 
nary  tract  for  the  presence  or  development  of  circulating  antibodies  utilizing  the 
more sensitive bacterial hemagglutination  technique  (17).  In contrast  to the obser- 
vations of Hughes,  significant titers of specific antibodies were present against 20 of 
the 40 antigens (organisms) isolated from these patients. These observations of Needell 
and coworkers have received confirmation by Slifkin, Ward,  Fischer,  and  Cromartie 
(18). 
The evidence here given is quite convincing that specific acquired immunity 
plays an important  role in the resistance  to many Gram-negative infections  in 
general; but in the  case of pyelonephritis  specifically, there is a  paucity of ex- 
perimental  data  as well as conflicting  results  from such  data as are available. 
The studies  which  form the basis of this  report demonstrate  that  specific im- 
munity  is  an  important  factor  in  the  development  of  acquired  resistance  in 
hematogenous experimental pyelonephritis. j.  P.  SANFORD,  B.  W.  HUNTER~  AND  L.  L.  SOUDA  385 
Methods 
Experimental hematogenous pyelonephritis was  produced  in  male rats of  the  Sprague- 
Dawley strain obtained from Holtzman Farms  (Houston,  Texas), weighing 200 to 300 gm, 
slightly modifying the technique described by  Braude, Shapiro, and Siemienski (19).  This 
consists of the intracardiac injection of 0.4 ml of an 18 hour trypticase soy broth (Baltimore 
Biological Laboratories) culture of the bacterial strain employed, followed by fight massage 
of the kidneys through the intact abdominal wall for a period of 2 minutes. The quantity of 
organisms injected ranged from 10  o to 10  n viable bacteria. 
Bacterial Straim.--The strain of Escherichia coli O-111 :B-4 was obtained from Dr. Richard 
T. Smith (originally obtained from Dr. P. R. Edwards). 
A strain of Escherichia coli O-22:K-negative was obtained from Dr.  William R. McCabe 
(15). 
TABLE  I 
Pydonephr#ogenidO ~  BacterialStrams(1  Week) 
Organisms 
E. co~ O-Ill:B-4 
Klebsiella  pneumo- 
niae  type  C 
(ATCC 10273) 
Proteus mirabilis 
Renal mampulation 
Renal massage 
No massage 
Renal massage 
No massage 
Renal massage 
No massage 
Number ] Gloss abscesses 
~n'Iral  I  (0 to 4+) 
32 
8 
25 
8 
21 
17 
1.1  +  0.81 
0  0 
0.8  -4-  0.8  5.6  -4-  1.8 
0  1.2 
1.5  4-  1.3  9.4  4-  2.7 
0.05  0.32  4-  0.1 
Number  Per cent 
M  n 1  n  kidneys kidneys  ea  og  um-~  Ph ~ 
ber organisms  [ ~  2~  [with > 
per gram kidney  o~an  log 2.0 
orgao 
Jams/gin 
100 
0 
25 
2 
21 
2 
0 
100 
25 
100 
12 
A  strain of Klebsiella type C  was obtained from the American Type  Culture Collection 
(ATCC 10273). 
A  strain of Proteus mirabilis was employed which had been isolated from a  patient with 
the clinical  diagnosis of  pyelonephritis.  This strain  has not  been  immunologically  char- 
acterized. 
All other strains of Escherichia coli were originally obtained from Dr. P. R. Edwards, with 
the exception of the Escherichia ¢oli 0-62, which was isolated from a patient with pyelonephritis 
and serologically identified by Dr. Edwards. 
The pyelonephritogenicity of the bacterial strains employed is tabulated  (Table I).  All 
strains uniformly produced pyelonephritis as evaluated by the appearance of gross abscesses 
and the persistence of viable bacteria within kidneys when intravascular administration was 
accompanied  by  light renal massage.  Intravascular administration without  renal massage 
infrequently resulted in spontaneous pyelonephritis. 
Evaluation of Renal Infections.--Experimental animals were sacrificed at varying inteJ vals 
and urine was obtained for culture through a  suprapubic incision. Tenfold serial dilutions of 
urine were made and pour plates performed utilizing MacConkey agar (Baltimore Biological 
Laboratories). At least 3  representative bacterial colonies were picked from each plate and 386  EXPERIMENTAL  HEM.A.TOGENOUS PYELONEPHRITIS 
tube agglutination tests performed utilizing appropriate antisera to  ascertain that  the or- 
ganisms isolated were those originally employed. 
The kidneys were removed aseptically and the extent of abscesses semiquantitated on the 
basis of 0 to 4-b. The presence of hydronephrosis, hydro-ureter, urinary tract calculi,  and 
infection of  seminal vesicles likewise  were semiquantitated. The  individual  kidneys were 
weighed, then ground with trypticase soy broth and sand using a mortar and pestle. The tissue 
suspension was  serially diluted  and  pour  plates  made  utilizing  MacConkey  agar.  Repre- 
sentative bacterial colonies were picked and tube agglutination tests performed. Numbers of 
bacteria were expressed per gram wet weight of renal tissue. 
Blood was obtained from animals by cardiac puncture and anticoagulated with sodium 
versenate. Blood urea nitrogen determinations were performed by the urease method of Karr 
(20). The mean normal value was 26.4 mg per cent ~  9.5 mg per cent. 
Serologic  Techniques.--Blood was obtained by means of intracardiac puncture, allowed  to 
clot, and the serum separated. 
E. coli O-111:B-4  antigen was prepared by either of the two following methods: 
(a)  Flasks containing 250 ml of trypticase soy broth were inoculated with 1 ml of E. toll 
from a growth of stock culture and incubated 18 hours at 37°C. Flasks were then placed in a 
boiling water bath for 2 hours, centrifuged, and the supernatant discarded. The sediment was 
resuspended in an equal volume of saline solution (250 ml), formalized (0.5 per cent), and 
stored at 4°C prior to use. 
(b) Flasks containing 20.5 liters of a buffered inorganic medium were inoculated with the 
E. coli O-111:B-4, incubated at 25°C (21). The organisms were sedimented, boiled, extracted 
with alcohol and  acetone, and  subsequently dried.  The  dried organisms were ground and 
stored at room temperature. 1 mg of dried antigen per ml of saline solution was used as the 
antigen. 
E. coli O-22:K-negative antigen was prepared in the fashion described under paragraph 
a above. 
KlebsieIla pneumoniae type C  was prepared from an encapsulated subculture. The sub- 
culture was inoculated into the desired volume of trypticase soy broth and incubated for 18 
hours at  37°C.  The culture was then centrifuged and resuspended in  an  equal  volume of 
isotonic saline solution. Formalin (0.5 per cent) was added to the solution,  which was  then 
stored at 4°C prior' to use. 
Proteus mirabilis antigen was prepared by the small volume technique utilized for the E. 
coli O-111 in paragraph a above. 
Antibody titrations  were determined by  agglutination  procedures  as  follows:  Twofold 
serial dilutions of rat serum were made with dilutions ranging from 1:2 to 1:16384,  using 4 
drop quantities of saline. An equal volume of antigen solution was added to each tube. Tubes 
~vere incubated at  56°C for 30  minutes, refrigerated for 48  hours at  4°C,  and macroscopic 
agglutination noted. 
Immunization Procedures.-- 
A. Immunization by previous  renal infection:  Acute pyelonephritis was produced by intra- 
vascular  injections of E.  coli O-Ill:B-4 and E.  coli O-22:K-negative and  allowed  to  heal 
spontaneously. Infection with Klebsiella pneumoniae type C and Proteus mirabilis was inter- 
rupted by a  2 week course of antibiotic therapy consisting of chloramphenicol 50 mg per kg 
twice daily, and kanamycin 50 mg per kg twice daily for a  period of 2 weeks.  The animals 
were then allowed a 7 day period for any residual antibiotics to be excreted or degraded. This 
therapeutic regimen was effective in eradication of the antecedent infection. 
B. Immunization by non-renal infection or killed bacteria:  Animals were immunized by the 
intravenous injection of viable E. coli O-111 :B-4 without renal massage. Without light renal 
massage,  bacterial multiplication within the kidneys did not occur. J'.  P.  $ANI~0RD~ B.  W.  HUNTER,  AND  L.  L.  SOD-DA  387 
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E.  coli O-Ill-antigen was prepared and 12.5  mg suspended in 1.0  ml complete Freund's 
adjuvant  (Difco) and injected subcutaneously. Antigen was also prepared by boiling an 18 
hour trypticase soy broth (Baltimore Biological Laboratories) culture of either E. eoli O-11 l:B- 
4 or Proteus mirabilis for 2 hours, followed by centrifugation and resuspension in 1:10 original 
volume of 0.9 per cent saline solution.  1.0 ml of this was injected subcutaneously on day  1 
and day 5. On day 7, 0.5 ml of a  1 : 1 dilution of the antigen was injected intravenously. 
C.  Passive immunization:  Rabbits weighing 3 kg received increasing quantities (0.5  to  10 
mg per injection) of  killed organisms by intravenous injection over a  3  week period.  The 
animals were bled and antisera preserved with 1 ml of 1 : 5000 merthiolate per 10 ml of serum 
and stored at --4°C. The rabbit antisera was administered in varying quantities by intravenous 
TABLE  II 
Course of Experimental H ematogenous E. eoli O-11h B-4 P ydonephritis 
Duration of infectlon  Number  Gri~s  t~ses 
2 
6 
46 
24 
32 
11 
21 
31 
8 
20 
2 
5 
9 
6 
10 minutes 
4 hrs. 
1 day 
2 days 
3  " 
4  " 
5  ~ 
6  " 
7  " 
9 to 10  " 
2 wks. 
3  " 
4  " 
5 to  6  " 
8  ~ 
10  " 
5 months 
6  " 
04-0 
0±0 
0±0 
0.87  ±  0.83 
1.5  :h  1.8 
1.4  -4-  0.91 
1.2  -4-  0.89 
1.3  -4-  1.1 
1.1  4-  0.81 
1.1  -4-  1.2 
1.1  4-  0.95 
0.23  4-  0.43 
0-+-0 
0±0 
04-0 
0+0 
0+0 
0±0 
Log of number 
organisms per 
gram kidney 
6.3  -4-  0.79 
5.3  4-  0.75 
9.0  4-  2.0 
8.7  4-  2.6 
5.64-  1.1 
4.7  -4-  2.7 
4.7  4-  2.1 
4.9  4-  2.2 
3.7  -4-  1.6 
2.6  -4-  1.9 
1.4  4-  1.6 
0.17  -4-  0.50 
0±0 
04-0 
04-0 
0~0 
Log of number 
organisms per 
milliliter urine 
5.0  -4-  0.69 
5.6  -4-  2.5 
5.0  ~  2.7 
Mean  titer 
0 
0 
0 
0 
0 
1/4 
1/64 
1/128 
1/256 
1/64 
1/32 
1/32 
1/4 
1/1 
inoculation at various intervals prior to bacterial challenge. The Klebsidla antisera was con- 
centrated by precipitation of the globulin by satured ammonium sulfate, then evaporated to 
1:30 of the original volume. The titer rose from 1:4 to 1:512. 
RESULTS 
Acute hematogenous pyclonephrkis was produced in rats, utilizing an 0-111 : 
B-4 strain of E.  coll. The course of infection due to this organism was predictable 
(Fig.  1, Table II). Rapid bacterial multiplication occurred within the kidney so 
that by 24 hours the number  of organisms reached  109 per gm of kidney.  Gross 
abscesses were  apparent by the 2nd day,  and contracted,  leaving residual scars 
and pitted areas over the subsequent 4  weeks.  Circulating antibodies began to j.  P.  SANFORD,  B.  W.  HUNTER,  AND  L.  L.  SOUDA  389 
appear by the 4th day and peak levels were reached by the 7th day. The acute 
infection was not associated with increases in blood urea nitrogen concentra- 
tions. 4 weeks following infection, the kidneys were sterile and in 42 rats sacri- 
ficed at intervals from 5 weeks to 6 months, the kidneys remained sterile. Thus, 
this strain of E. coli O-111 :B-4 produced acute pyelonephritis which was  self- 
limited and resulted neither in progressive infection with renal destruction nor 
in recurrent exacerbations of a low grade infection. 
Experiments  were  undertaken  to  produce  chronic  pyelonephritis  by  at- 
tempting repetitive infection with  the  original causative organism.  Following 
repetitive episodes of injection of organisms and renal massage, not only was 
chronic pyelonephritis not produced, but the rats showed no evidence of acute 
pyelonephritis. Hence, studies on the role of acquired resistance to reinfection 
were initiated. 
Various  methods  of  immunization  were  compared  (Fig.  2).  Injection  of 
Boivin-type endotoxin (somatic or O antigen) prepared from E. coli O-111 :B-4 
in  Freund's  adjuvant  rendered rats  considerably more resistant  than  simul- 
taneous controls to the development of pyelonephritis. A representative experi- 
ment comparing 10 rats immunized with Boivin-type endotoxin with  11 con- 
trol rats is recorded in Table III under column killed organisms.  Gross abscesses 
were reduced from 1.2-}- in controls to 0.4+ in immunized animals (P <  0.02) 
with a decrease in number of bacteria from a mean of 310,000 per gm to 1600 
per gm (P <  0.02). 
Rechallenge  of  animals,  which  had  previously  had  pyelonephritis caused 
by E. coli O-111 :B-4 which had been allowed  to heal spontaneously, with  E. 
coli O-111 :B-4 and associated renal massage resulted in a much lesser degree of 
infection  than  noted  in  controls.  Again,  a  representative  experiment  is  re- 
corded  (Table  III).  The differences between  "immunized"  rats  and  control 
rats are highly significant (P <  0.01).  Similar protection was noted when ani- 
mals were rechallenged at intervals of 1, 2, an 3 months following the  original 
infection. 
The effectiveness of passive immunization in enhancing resistance to subse- 
quent pyelonephritis is crucial to an evaluation of the role of immunity in re- 
sistance  to reinfection. The protection afforded by passive transfer of rabbit 
antiserum to rats was more difficult to demonstrate than the protection which 
followed active immunization. The quantity of antibody administered as well 
as the time required for complete equilibration in the recipient are critical to an 
interpretation of experiments. The results of repetitive individual experiments 
illustrate certain of the difficulties encountered (Table IV). In Experiment A, 
8 rats received 1.0 ml of rabbit anti-E, coli O-111 :B-4 antiserum 24 hours prior 
to challenge. The protection demonstrable when sacrificed 5 to 6 days subse- 
quently was equivocal, i.e., significant reduction in bacterial population within 
the kidneys but no significant alteration in gross pathology. In Experiment B, 390  EXPERI~ENTAL  HEMATOGENOUS  PYELONEPHRITIS 
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a similar protocol was followed; however, the prechallenge antibody titer in the 
recipient rats was 1 dilution higher (1 : 16) than in Experiment A. In this group 
of  animals significant diminution in gross  abscesses  was  observed;  bacterial 
counts were not performed. In the key Experiment, C, rats received 2.0 ml of 
rabbit anfisera having a  fiter of 1:256 72 hours and another 2.0 ml 4 hours be- 
TABLE Ill 
Effectiveness of Aai~e Immunization  in Experimental  Hematogeuous Pyelonephritis 
Suppression  at  5  to  10  Days  following  Challenge 
Type of active immunization 
Infecting organism  Prior infection  Killed organisms 
Number  animals  Gross  abscesses* 
E. coli 0-111 
Immunized ......  18  0.25  4.  0.41 
Control .........  21  1.1  4-  0.86 
p~ ..............  <0.01 
E. coli 0-22 
Immunized ......  7  0.51  4-  0.58 
Control .........  7  1.3  -4-  1.2 
P ...............  <0.05 
K. pneumoniae C 
Immunized  ......  8  O. 40  4-  0.49 
Control .........  43  0.64  4-  O. 88 
P ...............  >0.05 
Proteus mirabilis 
Immunized  ......  II  0  -4- 0 
Control .........  13  1.1  ±  1.4 
P ...............  <0.01 
Log 
organisms* 
2.3  -4-  2.2 
4.5  -4-  1.5 
<0.01 
3.4  ±  1.6 
4.8  ±  1.7 
<0.05 
3.5  4-  2.2 
5.0  4-  2.3 
<0.05 
1.7  -4- 2.9 
5.1  4.4.3 
<0.01 
Number  Gross abscesses*  animals 
10 
11 
Log 
organisms* 
0.40  4-  0.46  3.2  -4- 2.0 
1.2  4- 0.92  5.5  4-  1.9 
<0.02  <0.02 
0.40  4.  0.79  5.3  +  3.3 
2.3  4-  0.95  9.5  ±  2.9 
<0.01  <0.02 
* Mean  ±  S.D. 
:~ P based on method of Student t. 
fore  challenge.  The  passively tranferred  antibody afforded  a  significant de- 
crease in gross lesions as well as in the mean number of viable organisms from 
31,600 per gm of kidney to 160 per gm of kidney at 5 days following challenge 
(Table IV, Fig. 2). The regimen employed in Experiment C  assured complete 
equilibration prior to challenge and with the administration of approximately 
40 mg of rabbit globulin, immune rejection by the rat would not occur during 
the 5 day course of observation. The administration  of 1.0 ml volumes of rabbit 
antiserum 24 hours or less prior to challenge appeared to be suboptimal. 392  EXPERIMENTAL  HEMATOGENOUS  PYELONEPHRITIS 
The resistance which could be demonstrated following a variety of means of 
immunization was type-specific. Pyelonephritis was produced using the strain 
of E. coli O-111 :B-4, then allowed to heal, and the surviving animals were then 
rechallenged with heterotypic strains of E. coli which showed no in vitro cross- 
TABLE IV 
Effectiveness of Passive Immunization  in Experimental E. coU Pyelonephritis 
Organism 
E. coli 0-nl:B-4 
E. coli  0-22 
~bit antiserum 
Time before 
challenge Ab 
given 
1 day 
1 day 
2ml at 3 days 
2ml at 4 hrs. 
1 hr. 
1 to 3 hrs. 
3 hrs. 
Gross 
abscesses* 
(0 to 4+) 
0.60 4- 0.54 
0.90 4- 0.58 
>0.10 
0.40 4- 0.85 
1.8 4-  1.3 
<0.01 
0.31  4- 0.33 
1.5  4- 0.70 
<0.01 
0.08 -4- 0.19 
0.42  q- 0.60 
>0.05 
0.72  4- 0.71 
1.2  4- 0.86 
>0.03 
0.08 4- 0.84 
0.67  4- 0.24 
<0.01 
Log of num- 
ber org.* 
per gram 
kidney 
2.1  4-  1.9 
3.7 4-  1.4 
<0.01 
m 
2.2  4-  1.7 
4.5  4-  1.0 
<0.01 
4.7  4- 3.3 
8.9 4-4- 2.6 
<0.01 
4.4 4-  2.4 
5.0 4-  2.3 
>0.I0 
1.2  -4- 2.3 
3.7  4-- 2.2 
<0.01 
* Mean ±  S.D. 
P  based on method of Student  t. 
agglutination with the E. coli O-111 :B-4 (Fig. 3). Significant reduction in gross 
renal abscesses was not observed with any of the 4 heterotypic strains of E. coli 
or Mth a strain of Klebsiella pneumoniae type C. Of equal significance is the ob- 
servation  that  enhanced  suceptibility  to  reinfection  was  not  observed.  The 
course of repetitive sequential attempts at reinfection is depicted in Fig. 4.  A 
group of 100  rats was initially infected with E.  coli O-111 :B-4;  7 were  sacri- 
ficed to ascertain the magnitude of infection. 3 weeks later, 5 rats were sacri- ]. P.  SANFORD~  B.  W.  HUNTER~  AND  L.  L.  SOUDA  393 
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riced to be certain that the infection had healed.  The remainder of the original 
group was then challenged with E. coli 0-55 :B-5 and renal  massage along with 
an appropriate  control group of rats  which had not been previously infected. 
At  the  time of  challenge,  the  "healed"  rats  had  no  "cross"-agglutinin  titer 
against O-55:B-5. Neither  protection  nor  enhancement  of  infection  was  ob- 
served.  This  sequence  was  repeated  at  7  weeks  following  the  initial  E. 
coli O-111 :B-4 infection and 4 weeks  following the E. coli  0-55 :B-5  infection, 
with animals being challenged with E. coli O-26:B-6. At time of challenge, these 
animals exhibited a cross-reaction titer of 1:2 against the O-111 antigen and a 
titer  of  1:1  against  the  0-55  antigen.  With  this background,  significant pro- 
TABLE V 
Course of  Experimental Hematogenous E.  coli 0-22  Pyelonephritis 
Gross* abscesses  Log of number* organ-  Mean titer  Duration of infection  Number rats  (0 to 4+)  isms per gram kidney 
1 day 
2 days 
3  " 
5 to 6  " 
7  '~ 
12 to 14  " 
3 wks. 
4  " 
5.5 to 6  " 
8  ~c 
10  " 
4 
4 
4 
9 
14 
11 
7 
4 
7 
5 
4 
04-0 
0.75  4-  0.55 
0.88  4- 0.52 
1.5  4-  0.92 
0.73  4- 0.72 
0.77  4- 0.77 
0.40  4- 0.50 
0.13  4-  0.20 
0±0 
04-0 
04-0 
7.3  4-  2.9 
10.7  4-  1.6 
7.8  4-  2.1 
4.8  4-  1.7 
4.3  4-  1.6 
3.7  -4=  1.9 
2.8  -4-  1.4 
2.2  4-  0.68 
2.1  4-  1.7 
1.24-1.1 
0±0 
0 
0 
1/512 
1/1024 
1/256 
1/64 
1/64 
1/64 
1/16 
1/1 
* Mean  -4- S.D. 
tection was demonstrated.  3  weeks  later,  when  E.  coli  O-86:B-7 was  utilized 
significant protection was again demonstrated.  Finally,  16 weeks following the 
initial challenge, the remaining rats were challenged with E. coli O-1. These rats 
which had by then  received E. coli  O-111 :B-4, 0-55 :B-5, O-26:B-6, and  0-86: 
B-7 had no agglutinins against the E. coli O-1 in their sera. The magnitude of the 
E. coli O-1 infection in the repeatedly infected animals did not differ from pri- 
mary E. coli O-1 infection. Thus, 4 previous episodes of acute infection, at least 
2 of which were severe, did not enhance susceptibility to a subsequent episode of 
hematogenous pyelonephritis. 
Observations similar to those made with the E. coli O-111 :B-4 were  then  re- 
peated with a strain of E. coli  0-22 :K-negative. The course of the experimental 
infection  was  similar  to  that  observed  with  the  O-Ill:B-4  strain  of E.  coli 
(Fig. 5, Table V). The duration of infection with the E. coli 0-22 was somewhat 
longer than that observed with E. coli O-111. However, by the  10th week the j.  P.  SAN~'ORD,  ]3.  W.  HUNTER,  AND  L.  L.  SOUDA  397 
kidneys were sterile and in animals sacrificed as late as 14 weeks recrudescence 
of infection was not observed. 
Rechallenge with the homotypic organism, E. coli 0-22, following healing of 
antecedent  infection afforded protection as measured by significant decreases 
in gross renal abscesses and viable organisms in the kidneys (Fig. 6, Table III). 
The  protection  afforded by the passive transfer  of  rabbit  anfi-E,  coli  0-22 
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FIG. 6.  Effectiveness of immunization in the prevention of acute hematogenous E. coli 
0-22 pyelonephritis (suppression of infection at 1 week). 
antiserum was variable (Table IV, Fig.  6).  1 ml of  antiserum with a  titer  of 
1:1024 was administered  1 to 3 hours prior to challenge. This volume and in- 
terval subsequently were shown to be suboptimal. The data from Experiment 
B  are illustrated in Fig. 6 and show no protection; however, in the 2 other ex- 
periments significant protection resulted. 
Similar observation of healing by 4 weeks was observed in groups of 10 to 15 
rats infected with the following strains of E. coli: 0-1, 0-2, 0-3, and 0-5. These 
were evaluated as the lower serotypes of E.  coli may predominate in clinical 
urinary tract infections (22). 398  EXPERIMENTAL  ItEM.ATOGENOUS  PYELONEPHRITIS 
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In evaluating the specificity of the immune response to E. coli  O-111 :B-4, a 
strain of KlebsieUa pneumoniae type C  was employed. It was observed that the 
pyelonephritis produced by this bacterial strain did not heal as promptly as ob- 
served with  the strains of E. coli.  Hence,  the  course of hematogenous  pyelo- 
nephritis due to this strain was defined (Fig. 7, Table VI). It will be noted that 
bacterial multiplication within  the  kidneys  was  not  as  marked  as  with  the 
strains of E. coli,  the peak bacterial density reaching approximately l0  s viable 
organisms per gm of kidney. However, viable bacteria  persisted  in relatively 
small numbers throughout the duration of observation,  24 weeks.  Despite  the 
TABLE VI 
Course of Experimental Hematogenous Klebsiella Type C Pydonephritis 
Duration of infection 
1 day 
2 days 
3  " 
4 to 6  " 
7  " 
8  " 
2 to 3 wks. 
4  '~ 
6  " 
8  " 
10.5 to 12  " 
16.5 to 19  " 
24  " 
Number 
rats 
2 
2 
2 
43 
25 
8 
19 
10 
10 
5 
8 
6 
5 
Gross* abscesses 
(0 to 4+) 
0 
0.12 
0.50 
0.64 
0.80 
1.3 
1.5 
0.50 
0.15 
0 
0.20 
0 
0.05 
Log of number* 
organisms per 
gram kidney 
-4-0 
±  0.25 
4- 0.40 
4- 0.88 
4- 0.83 
4-  1.3 
4-1.1 
•  4- 0.92 
4- 0.22 
4-0 
4- 0.40 
4-0 
4- 0.16 
4.8  4-  1.0 
5.5  q- 0.71 
5.6  4-  1.3 
5.0  4- 2.3 
5.6  4-  1.8 
5.5  4- 2.3 
3.6  -t: 2.2 
2.7  4- 2.2 
3.4  4-  2.2 
1.9  4-  1.8 
2.4  4-  1.6 
1.2  4-  1.4 
3.8  4-  1.6 
Log of number* 
organisms per 
miUiliter urine 
u 
4.2  4-  2.1 
7.2  4-2.1 
Mean tlter 
0 
0 
0 
1/1 
1/1 
1/1 
0 
0 
1/1 
0 
0 
* Mean -4- S.D. 
chronicity of infection, the blood urea nitrogen levels remained normal through- 
out the period of observation. Animals developed neither renal calculi nor hy- 
dronephrosis. In contrast to the prompt agglutinin responses that were observed 
with the strains of E. coli,  there was virtually no agglutinin response demon- 
strable against encapsulated strains of K. pneumoniae. However, high titers of 
antibodies could be demonstrated when non-encapsulated variants of K./meu- 
moniae C were used as antigen rather than encapsulated variants. 
The persistence of infection with K. pneumoniae  as well as the difficulty in 
stimulating  capsular  antibodies  made  evaluation  of  immunization  difficult. 
The  role  of  antecedent  infection  in  enhancing  resistance  to  reinfection  was 
studied in rats which had been infected but in which the infection was cured by 
a  course of antibiotics, chloramphenicol 100 mg per kg per day and kanamycin 
100 mg per kg per day for 2 weeks. When "cured" animals were rechallenged 400  EXPERIMENTAL HENIATOGENOUS  PYELONEPI-IRITIS 
with  the homotypic strain,  a  decrease  in gross renal  infection did not result; 
however, the number of viable organisms was reduced from a  mean of 100,000 
per gm, to 3100 per gm kidney (P <  0.05)  (Fig. 8, Table III). Thus, in contrast 
to the  results  observed with  strains  of  E.  coli,  the  resistance  to  reinfection 
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FIG. 8.  Effectiveness of immunization in the prevention  of hematogenous Klebsiella type 
C pyelonephritis (suppression of infection at 1 week). 
following eradication  of previous  infection was  at  best  equivocal,  which was 
not  surprising in that infection failed to evoke a significant immune response. 
Passive  transfer  of resistance  was  attempted  by administering  rabbit  anti- 
capsular Klebsiella  antibody which had been concentrated by ammonium sul- 
fate precipitation and evaporation. Significant protection was demonstrated in 
Experiment B in which the antiserum was administered  24 hours prior to chal- 
lenge and the recipients' mean titer was 1:64 at the time of challenge (Fig. 8, 
Table VII). The other 2 experiments were not satisfactory; in 1, the antiserum 
was administered  1 hour prior to challenge and in the other, the recipient titer 
at 24 hours was 1 : 16. j.  P.  SANFORD,  B.  W.  HUNTER,  AND  L.  L.  SOUDA  401 
The same experimental design was extended to a  strain of Proteus mirabilis 
(Figs.  9,  10,  Table VIII). The  course  of pyelonephrifis associated  with  this 
bacterial strain is quite different from that observed with either strains of E. 
coli or K. pneumoniae.  Bacterial multiplication was prompt and high bacterial 
TABLE Vll 
Effectiveness of Pozsive Immunization  in Experimental  Proteus  and  Klebsidla 
Pyelonephritis 
Organism 
~,lebsidla 
type C 
Proteus 
mirabi- 
lis 
Rabbit antiserum 
Mean  Num-  Time of  Gross abscesses* 
Experiment No.  rat  Time  ber  autopsy  (0 to 4+) 
rats  titer  Injected  before 
challenge 
Ab given 
A 
Immunized  1:64 
Control  0 
P~ 
r,d  days 
1 (conc.  lhr.  4  6to 70.69  4- 0.65 
Ab) 
0  --  5  0.30  4- 0.79 
> 0.50 
B 
Immunized  1:64  1 (conc.  lday  4  6to 70.36  4- 0.36 
Ab) 
Control  0  0  --  7  1.3  4-  0.95 
P  <0.01 
C 
Immunized  1:16  1 (conc.  lday  8  6to 70.21  q-  0.36 
Ab) 
Control  0  0  --  10  0.47  4- 0.44 
P  >0.05 
Immunized  1:40  1  Iday  10  6to 70.04 4- 0.12 
Control  0  0  --  9  0.51  4- 0.46 
P  <0.01 
Log of number 
org.* ~:)er gram 
kidney 
5.1  4-  2.0 
4.4  4-  2.8 
>0.50 
4.4  4-  1.4 
6.3  4-  1.6 
<0.01 
4.5  ±  1.4 
5.2  4-  1.8 
>0.10 
1.4  4-  3.0 
5.4  4-  2.0 
<0.01 
* Mean  .4-  S.D. 
$ P based on method of Student t. 
concentrations were  reached.  Further,  high  bacterial  populations  persisted 
throughout 22 weeks of observation. This infection carried a  continued mor- 
tality throughout a period of observation with 34 per cent of one group of 130 
rats dying of infection in a 6 week period. Deaths which occurred were the con- 
sequence of renal insufficiency with most animals having blood urea nitrogen 
levels of >  100 mg per cent, reaching as high as 660 mg per cent. Infection with 
this  P.  mirabilis  was  also  associated  with  rises in agglutinin fiter,  the  mean 402  EXPERIMENTAL  HEMATOGENOUS  PYELONEPHRITIS 
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value reaching 1:1280 by the 6th day and remaining in the 1:160 range through- 
out 22 weeks of observation. The striking difference between infection with this 
strain of P. mirabilis and that produced by E. coli and K. pneumoniae  C was the 
development of extensive calculi in the bladder and renal pelvis, with associated 
hydronephrosis. Calculi began to appear with frequency during the 2nd week, 
and increased during the period of observation. 
The  effectiveness  of  active  immunization  in  producing  resistance  to  rein- 
fection with P. mirabilis  was evaluated both by eradication of established pre- 
vious infection with  antibiotics,  then  rechallenge, and by immunization with 
TABLE VIII 
Course of Experimental Hematogenous  Proteus Pydonephritis 
Duration of 
infection 
1 day 
2 days 
3  ~c 
4  cc 
6  " 
7  " 
2 wks. 
3  " 
4 to 5  " 
6  " 
7to8  " 
9 to 12  " 
15  " 
~nlI1- 
bet 
rats 
3 
3 
6 
2 
16 
21 
41 
22 
15 
25 
14 
9 
9 
Gross* abscesses 
(0 to 4+) 
0.17  -4- 0.26 
0.58  4- 0.20 
0.89  4- 0.77 
2.0  4-  1.3 
0.93  4-  1.2 
1.5  4-  1.3 
1.4  4-  1.4 
0.81  4-  1.2 
1.7  4-  1.4 
1.0  4-  1.2 
1.9  4-  1.3 
1.4  ±  1.4 
1.5  4-  1.6 
Log of.number* 
orga,  nlsms per 
gram kidney 
7.1  4- 2.2 
6.9  4- 0.81 
6.04-  2.1 
7.1  4-  2.3 
6.0  4-  3.5 
9.4  4-  2.7 
5.4  4- 4.4 
4.3  -4- 4.4 
7.9  4- 4.0 
4.5  4- 4.0 
7.1  4-3.4 
6.6  4- 4.5 
6.0  4- 4.0 
Mean til 
0 
0 
1/5 
1/640 
1/128q 
1/128~ 
1/320 
1/16o 
1/40 
1/16o 
1/16o 
1/16o 
1/8o 
Stones*  (0 to 4+) 
0.60  4- 0.61 
0.10  4- 0.22 
0.34  4- 0.41 
0.64  4- 0.83 
0.32  4- 0.77 
2.8  4-  1.6 
1.8  4-  1.6 
3.0  4-  1.6 
2.8  4-  1.7 
2.8  4-  1.7 
Blood urea* 
nitrogen 
rag per cent 
29.0  4-  1.8 
48.1  4- 48.8 
95.0  4-  101.2 
40.0  4-  16.7 
39.0  4- 32.6 
44.1  4-  11.7 
95.0  4- 62.5 
59.0  4- 58.5 
85.0  4- 50.7 
96.0  -4- 96.6 
* Mean 4- s.D. 
killed whole bacterial cells. Both methods of immunization afforded significant 
protection (Fig. 11, Table III). Rats were passively immunized with 1.0 ml of 
rabbit antisera which had a  titer of 1:640 with resultant prechallenge titers of 
1:40  in  the  recipients  (Table  VII).  The  combined  mortality in  the  immune 
groups was  10 per cent as compared with 39 per cent in controls (P  =  0.05). 
Significant protection as measured by reduction in gross renal damage as well 
as reduction in viable organisms was demonstrated. 
DISCUSSION 
These studies  demonstrate  that when  resistance to  pyelonephritis was suc- 
cessfully produced, the resistance was mediated at least in part, if not entirely, 
by  the  development  of specific acquired immunity.  The  enhanced  resistance 
against the induction of pyelonephritis has the characteristics which are asso- 406  EXPERIMENTAL  HEMATOGENOUS  PYELONEPHRITIS 
dated with classical acquired immunity due to  circulating antibodies.  First, 
the resistance was type-specific. Both early non-specific  resistance and toler- 
ance are classically not type-specific but are shared between various species of 
Gram-negative bacteria. Second,  resistance could be passively transferred by 
rabbit antiserum in each of the 4 experimental infections studied. These experi- 
ments are crucial to this hypothesis since the protective capacity of passively 
transferred antibody excludes not only tolerance, but also delayed hypersensi- 
tivity as the sole mechanism of protection. Third, the protection was of con- 
siderable duration, having been demonstrated 3 months following primary in- 
fection. Since resistance to reinfection was type-specific, of prolonged duration, 
and passively transferred by immune serum, it is concluded that the protection 
is the consequence of active immunity. 
It can be  argued  that specific  immunity could confer resistance  to pyelo- 
nephritis  either by promoting the more  rapid removal of bacteria  from the 
circulation, thereby diminishing the inoculum to which the kidney was exposed, 
or by markedly retarding  the  multiplication of bacteria  within  the  kidney. 
While  the  former  mechanism  would  not  negate  the  validity  of  these 
observations, it would lessen their biological significance, as there is considerable 
evidence that the ascending route of infection is of major consequence in the 
pathogenesis  of  pyelonephritis  (23,  24).  The  evidence  from  the  present 
studies, as well as other lines of evidence, strongly supports the hypothesis that 
bacterial multiplication within the kidneys is suppressed.  In experiments in- 
volving both E. coli O-111 :B-4 and O-22:K-negative, immunized and control 
animals were sacrificed 10 minutes following challenge and renal massage. The 
bacterial concentrations in kidneys of the immunized animals were essentially 
equal to those in the control animals, differences being less than 1 log  1° per gm 
of tissue. Also, in subsequent studies we have been able to demonstrate that 
prior infection and immunization with killed organisms results in resistance to 
ascending infection caused by the strain of Proteus  mirabilis  (25).  These ob- 
servations are substantiated by the findings of Braude and Siemienski, who re- 
ported that clearance of E. coli from the blood during the first 5 minutes was 
not increased by immunization (3).  Thus,  whatever other protective  effects 
specific immunity exerts, a  major action is retardation of bacterial growth in 
the kidney. 
Actually three  patterns  of immunologic response  to  hematogenous pyelo- 
nephritis were demonstrated depending on the specific  organism involved. In 
the first, some bacterial strains, as typified by E. coli, evoke formation of type- 
specific  antibodies  which  are  responsible  for  the  comparatively  short  self- 
limited course and marked resistance to reinfection with the same strain. 
In the second pattern, which is typified by K. pneumoniae  type C, the in- 
fection is  of prolonged duration and resistance to  reinfection with  the  same 
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to organisms present in the kidney or to reinfection appears  to be the specific 
consequence of a poor immunologic response rather than a non-protective  effect 
of the antibody. The immune response against the capsular polysaccharide  is 
poor and erratic during all phases of renal infection. However, protection was 
afforded  by  the  passive  transfer  of  concentrated  antiserum,  which  clearly 
demonstrates that the failure of the rat to elicit a vigorous immune response 
against the capsular  antigen of K. pneumoniae  is an important factor in the 
chronicity of pyelonephritis  caused by this organism. 
The  third pattern,  typified by the  course  of  experimental  hematogenous 
pyelonephritis due to Proteus mirabilis,  is characterized  by a vigorous immune 
response;  nevertheless,  chronic  progressive  infection rather  than self-limited 
disease ensues. The apparent failure of antibodies  to modify the course of in- 
fection might be the result of measurement of agglutinins  which are not pro- 
tective. These circumstances might be analogous either to the failure of O anti- 
body to protect mice against challenge with an O-inagglutinable  strain of S. 
typhosa  (9) or to the failure of O antibody to protect rats against homotypic 
reinfection with encapsulated strains of K. pneumoniae type C, as demonstrated 
in these  studies.  However,  in contrast to the observations  on K. pneumoniae 
type C, following eradication of active P. mirabilis  infection animals were re- 
sistant to reinfection  with the same strain of P. mirabilis.  As the agglutinins 
which developed  during  the  course  of  infection were  capable  of  protecting 
against reinfection,  the apparent failure of antibodies  to modify the course of 
infection must be the consequence of other factors. While further dissection of 
these factors will be presented,  it appears that the introduction of urinary tract 
obstruction secondary to calculi which uniformly develop during the course of 
infection with P. rnirabilis converts  an infection which would be self-limited 
into chronic progressive pyelonephritis as a  result of endogenous obstruction 
despite the presence of protective antibody (26). In an experiment designed to 
evaluate the role of protective antibody in the presence of obstruction, glass 
beads were inserted into the bladders of rats through a cystotomy. These rats 
were subsequently challenged by intravascular inoculation of E. coli 0-111 :B-4 
and renal massage. In contrast to the observations  presented in detail in this 
paper, in this experiment  6 of 16 rats did not spontaneously heal by 4 weeks, 
but had infection 6 weeks later with mean bacterial counts of 16,000 per gm of 
kidney. Thus, active type-specific immunity is an important determinant in 
the course of experimental  hematogenous  pyelonephritis  primarily in the ab- 
sence of obstructive uropathy. The mechanism  in P. mirabilis  pyelonephritis 
whereby calculi with associated  obstruction nullifies the protective action of 
antibody  is not clear. Beeson and Rowley  have demonstrated that renal homog- 
enates exert an anticomplementary action involving inactivation of the fourth 
component of complement,  probably through the formation of ammonia (27). 
Pyelonephritis due to Proteus mirabilis,  more so than pyelonephritis with non- 408  EXPERIMENTAL  H.E~IATOGENOUS  PYELONEPHRITIS 
urea-splitting organisms, would be associated with extremely high urinary con- 
centrations of ammonia which in turn might be associated with high concentra- 
tions of ammonia in the renal papillae. Such a mechanism might account for the 
nullification in protective action of antibody in obstructive P. mirabilis pyelo- 
nephritis. 
Failure to appreciate this relationship may account for the earlier conclusions 
that immunity has little significance in clinical pyelonephritis, particularly in 
the studies of Weyrauch, Rosenberg, Amar, and Redor  (13).  These  authors 
demonstrated a  diminution in "severe" infection from 96 per cent in control 
rabbits to 25 per cent in a group of 16 rabbits immunized with autogenous E. 
coli vaccine.  Their experimental model involved partial ureteral ligation and 
resulted in moderate hydronephrosis. The importance of obstruction in modi- 
fying the effect of type-specific immunity may well account for the failure to 
demonstrate a  reduction in  the  bacterial  count in  the  kidneys of rats  with 
Proteus  mirabilis pyelonephritis following immunization, reported by Braude 
and  Simienski  (3). 
Clinical observations contribute very little to elucidation of the role of en- 
hanced resistance to reinfection since specific serotyping of causative organisms 
has seldom been sequentially performed. However, the impressions of Martin, 
Bronstein, and Dray are extremely interesting and pertinent. They noted that 
pyelonephritis is very common in patients with agammaglobulinemia, and that 
they will develop it despite the absence of any obstructive phenomena in the 
genitourinary tract (28). 
SUMMARY 
Hematogenous pyelonephritis was produced in rats utilizing multiple strains 
of Escherichia  coli, a  strain of Klebsielh~ pneumoniae,  and a  strain of Proteus 
mirabilis. 
Three patterns of hematogenous pyelonephritis occurred which represent an 
interrelationship between an immune response to the infecting bacteria and the 
development of obstructive uropathy as a consequence of infection. First, the 
course of pyelonephritis due to strains of Escherichia coli was acute, self-limited, 
and  associated  with  the  development  of  circulating  agglutinins.  Following 
healing, this pattern of infection was associated with acquired resistance to re- 
infection with the same bacterial strain. Second, the course of pyelonephritis 
due to a strain of Klebsiella pneumoniae  type C was chronic. This infection was 
not associated with the production of circulating agglutinins against encapsu- 
lated strains. Acquired resistance to reinfection by the homotypic strain could 
not be demonstrated following eradication of infection but was produced by the 
passive transfer of concentrated antiserum. Third, pyelonephritis due to Proteus 
mira.bills  was  associated with circulating agglutinins and  resistance  to  rein- 
fection with the same organism following eradication of infection, yet the course j.  p.  SANFORD,  B.  W.  HUNTER,  AND  L.  L.  SOUDA  409 
was  chronic. The  chronicity appeared  to be  the  consequence of obstructive 
uropathy resulting from calculi which developed during the course of the infec- 
tion. 
Resistance to reinfection was demonstrated in infections with strains of E. 
coli and P. mirabilis.  The resistance is  associated with  specific immunity as 
demonstrated by the observation that: (a) it is type-specific, (b) it is of at least 
3 months' duration, and (c) it can be passively transferred by means of rabbit 
antiserum. Since K. pneumoniae failed to evoke capsular antibodies in the rat, 
resistance to infection with  K.  pneumoniae  was  produced only by means  of 
passively transferred concentrated rabbit antiserum and not by prior infection. 
Immunity can be demonstrated to have a significant role in the pathogenesis 
of experimental hematogenous pyelonephritis only in the absence of obstructive 
uropathy. 
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